Company intelligence / Profile preview

Canntab Therapeutics Limited

Markham, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Developing pharmaceutical-grade oral solid dosage forms of cannabinoids including extended release, immediate release, and bi-layer tablets; seeking regulatory approvals in Canada and partnerships for commercialization; no advanced clinical trial data reported.

Therapeutic areas: RheumatologyPsychiatryNeurologyOncology
Modalities: Small molecule
Industry: Biotech

Partnerships

Emblem Corp.FSD Pharma Inc.World Class Extractions Inc.Exactus Inc.Queensland Bauxite Ltd. / Vitacan Pty Ltd.Pathway

Beyond the preview

Go deeper on Canntab Therapeutics Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canntab Therapeutics Limited.

Explore the full profile